JPMorgan Starts CellaVision AB (CLVS) at Overweight
Tweet
Share
E-mailGet Alerts CLVS Hot Sheet
Price: $0.08 --0%
Rating Summary:
7 Buy, 7 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
7 Buy, 7 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
JPMorgan initiates coverage on CellaVision AB (NASDAQ: CLVS) with an Overweight. PT $20.00.
For an analyst ratings summary and ratings history on CellaVision AB click here. For more ratings news on CellaVision AB click here.
Shares of CellaVision AB closed at $14.30 yesterday.
For an analyst ratings summary and ratings history on CellaVision AB click here. For more ratings news on CellaVision AB click here.
Shares of CellaVision AB closed at $14.30 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Starts Kanzhun Ltd. (BZ) at Neutral
- BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
- Wedbush Starts Immunic Inc. (IMUX) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
